These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7882976)

  • 21. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
    Shimon I
    Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
    Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
    Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.
    Chen L; Hoeger C; Rivier J; Fitzpatrick VD; Vandlen RL; Tashjian AH
    Biochem Biophys Res Commun; 1999 May; 258(3):689-94. PubMed ID: 10329447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor.
    Nagel F; Doll C; Pöll F; Kliewer A; Schröder H; Schulz S
    Mol Endocrinol; 2011 May; 25(5):859-66. PubMed ID: 21330405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological detection of isoforms of the somatostatin receptor subtype, SSTR2.
    Theveniau MA; Yasuda K; Bell GI; Reisine T
    J Neurochem; 1994 Aug; 63(2):447-55. PubMed ID: 7518495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice.
    Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ
    Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides.
    Corness JD; Demchyshyn LL; Seeman P; Van Tol HH; Srikant CB; Kent G; Patel YC; Niznik HB
    FEBS Lett; 1993 Apr; 321(2-3):279-84. PubMed ID: 8097479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of somatostatin receptor subtypes.
    Bruns C; Weckbecker G; Raulf F; Lübbert H; Hoyer D
    Ciba Found Symp; 1995; 190():89-101; discussion 101-10. PubMed ID: 7587655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
    Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
    Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants.
    Ishii I; Izumi T; Tsukamoto H; Umeyama H; Ui M; Shimizu T
    J Biol Chem; 1997 Mar; 272(12):7846-54. PubMed ID: 9065450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
    Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum.
    Piwko C; Thoss VS; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):607-13. PubMed ID: 9053731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.
    Yamada Y; Post SR; Wang K; Tager HS; Bell GI; Seino S
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):251-5. PubMed ID: 1346068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
    Hadcock JR; Strnad J; Eppler CM
    Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
    Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pharmacology of somatostatin receptors.
    Viollet C; Prévost G; Maubert E; Faivre-Bauman A; Gardette R; Kordon C; Loudes C; Slama A; Epelbaum J
    Fundam Clin Pharmacol; 1995; 9(2):107-13. PubMed ID: 7628822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
    Reubi JC; Schaer JC; Waser B; Mengod G
    Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995.
    Fujii Y; Gonoi T; Yamada Y; Chihara K; Inagaki N; Seino S
    FEBS Lett; 1994 Nov; 355(2):117-20. PubMed ID: 7982482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.
    Zatelli MC; Piccin D; Bottoni A; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Taylor JE; Culler MD; Cavazzini L; degli Uberti EC
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5181-8. PubMed ID: 15472224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.